What is the market doing?
What the tape says about CLDX
Celldex Therapeutics, Inc. is +60% over the past year while the S&P 500 is +20%: 39 points ahead of the market.
+60%
1-year return · S&P 500 +20%
- vs 200-day average
- +27%
vs 200-day average · a clear uptrend
- RSI (14)
- 32
RSI (14) · neutral
- Below its 52-week high
- 13%
Below its 52-week high
Details›
- Last close2026-09-08
- $39.13
- 1 monthS&P 500 −0.30%
- −5.9%
- 1 yearS&P 500 +20%
- +60%
- 5 yearsS&P 500 +85%
- −9.5%
- vs 50-day average$37.49
- +4.4%
- 52-week high
- $44.88
- 52-week low
- $20.89
- Annualised volatility
- 58%
| Year | Return |
|---|---|
| 2026 (year to date) | +44% |
| 2025 | +7.5% |
| 2024 | −36% |
| 2023 | −11% |
| 2022 | +15% |
| 2021 | +121% |
| 2020 | +686% |
| 2019 | −26% |
| 2018 | −93% |
| 2017 | −20% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 3 of 10 | +13% |
| Feb | 10 | 5 of 10 | +3.5% |
| Mar | 10 | 4 of 10 | −8.4% |
| Apr | 10 | 4 of 10 | −2.2% |
| May | 10 | 2 of 10 | −9.5% |
| Jun | 10 | 7 of 10 | +41% |
| Jul | 11 | 7 of 11 | +1.5% |
| Aug | 11 | 7 of 11 | +1.6% |
| Sep | 11 | 6 of 11 | +4.0% |
| Oct | 10 | 4 of 10 | −8.7% |
| Nov | 10 | 8 of 10 | +12% |
| Dec | 10 | 4 of 10 | −2.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.